SCHEDULE: Royce & Associates LP Maintains 5.95% Stake in Apyx Medical

Investment adviser Royce & Associates LP has filed an amendment to its Schedule 13G, reporting a 5.95% beneficial ownership stake in Apyx Medical Corporation.

Summary

• Royce & Associates LP, an investment adviser, reported beneficial ownership of 2,443,035 shares of Apyx Medical Corporation common stock.
• This represents 5.95% of the class of securities.
• The firm holds sole voting power and sole dispositive power over all 2,443,035 shares.
• The filing is an Amendment No. 3 to a Schedule 13G, indicating a continued or updated significant institutional holding.
• Royce & Associates LP certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Apyx Medical Corporation.
• Royce & Associates LP is an indirect majority-owned subsidiary of Franklin Resources, Inc. (FRI) and exercises investment discretion and voting authority independently.

Sentiment

Score: 7

Explanation: The filing indicates continued significant institutional interest in Apyx Medical Corporation by a reputable investment adviser, which is generally a positive signal for the company's stability and investor confidence, without any negative disclosures or changes in investment intent.

Positives

• Continued significant institutional ownership by a reputable investment adviser, Royce & Associates LP, which can signal confidence in the company's long-term prospects.
• The investment is held in the ordinary course of business, indicating a passive investment strategy rather than an activist one, which can provide stability.

Future Outlook

NA

Industry Context

Schedule 13G filings are common disclosures by institutional investors holding more than 5% of a company's stock, indicating a passive investment intent. This filing shows continued institutional interest in Apyx Medical Corporation, suggesting that a significant investment adviser maintains a notable position in the company.

Comparison to Industry Standards

• Institutional ownership levels are a key metric for assessing a company's investor base. A 5.95% stake by a single investment adviser like Royce & Associates LP is a notable position, often seen as a positive signal by other investors.
• Compared to activist investors who file Schedule 13D, Royce & Associates LP's 13G filing indicates a passive investment, aligning with typical institutional fund management strategies and suggesting no immediate intent to influence corporate control.

Stakeholder Impact

• Shareholders: The continued significant stake by Royce & Associates LP may be viewed positively, potentially signaling confidence in the company's value and stability.
• Company Management: Awareness of a significant institutional holder can influence strategic decisions, though Royce & Associates LP explicitly states a passive investment intent.

Next Steps

• Apyx Medical Corporation will continue its operations.
• Royce & Associates LP will continue to manage its investment in Apyx Medical Corporation as part of its ordinary course of business.

Key Dates

Recommendation

The filing indicates a stable, significant institutional ownership position by Royce & Associates LP. This suggests a level of confidence from a professional investment adviser, which can be a positive indicator for existing shareholders. Without additional financial or operational news from Apyx Medical Corporation, maintaining a 'Hold' position is prudent, acknowledging the institutional backing while awaiting further company-specific developments.

Keywords

Apyx Medical Corporation, Royce & Associates LP, Schedule 13G, beneficial ownership, institutional investor, common stock, investment adviser, APYX